At the same time, the release of DAMPs, HMGB1 and ATP, were detected, suggesting that GSDME may mediate paclitaxel-induced pyroptosis in breast cancer cells through the caspase-9/caspase-3 pathway. Here, CASP9 is linked to breast carcinoma.